These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21478217)

  • 1. Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.
    Meijvis SC; Cornips MC; Voorn GP; Souverein PC; Endeman H; Biesma DH; Leufkens HG; van de Garde EM
    Eur Respir J; 2011 Nov; 38(5):1165-72. PubMed ID: 21478217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
    Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
    Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
    Giuliano C; Wilhelm SM; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
    Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J
    Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors: bacterial pneumonia.
    Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid inhibition and infections outside the gastrointestinal tract.
    Vakil N
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S17-20. PubMed ID: 19262541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.
    Johnstone J; Nerenberg K; Loeb M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and the risk of colorectal cancer.
    van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ
    Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
    Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
    Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
    Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
    Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
    Sarkar M; Hennessy S; Yang YX
    Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
    van Vlerken LG; Huisman EJ; van Hoek B; Renooij W; de Rooij FW; Siersema PD; van Erpecum KJ
    Eur J Clin Invest; 2012 Jul; 42(7):760-7. PubMed ID: 22288900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.
    Ratuapli SK; Ellington TG; O'Neill MT; Umar SB; Harris LA; Foxx-Orenstein AE; Burdick GE; Dibaise JK; Lacy BE; Crowell MD
    Am J Gastroenterol; 2012 May; 107(5):730-5. PubMed ID: 22334250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.
    Kaye JA; Jick H
    Pharmacotherapy; 2008 Aug; 28(8):951-9. PubMed ID: 18657011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.